Cingulate (CING) Institutional Ownership $4.32 +0.10 (+2.25%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$4.34 +0.02 (+0.46%) As of 02/21/2025 06:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Cingulate (NASDAQ:CING)CurrentInstitutional OwnershipPercentage41.31%Number ofInstitutional Buyers(last 12 months)5TotalInstitutional Inflows(last 12 months)$578.66KNumber ofInstitutional Sellers(last 12 months)0 Get CING Insider Trade Alerts Want to know when executives and insiders are buying or selling Cingulate stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CING Institutional Buying and Selling by Quarter Cingulate Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/12/2025 Geode Capital Management LLC27,323$135K0.0%N/A0.851% 2/10/2025 Commonwealth Equity Services LLC43,022$212K0.0%+281.5%1.340% 1/21/2025 AlphaMark Advisors LLC5,010$25K0.0%+50,000.0%0.156% 11/15/2024 Jane Street Group LLC21,031$106K0.0%N/A0.655% 8/15/2024 Armistice Capital LLC490,000$157K0.0%N/A6.671% 11/15/2023 Armistice Capital LLC754,792$535K0.0%N/A4.820% 10/23/2023 Commonwealth Equity Services LLC100,771$71K0.0%N/A0.643% 5/5/2023 Prime Capital Investment Advisors LLC48,262$48K0.0%N/A0.413% 11/8/2022Eagle Asset Management Inc.107,527$115K0.0%+124.5%0.951% 5/12/2022Eagle Asset Management Inc.47,895$94K0.0%N/A0.424% 5/5/2022Lynwood Capital Management Inc.225,994$445K0.5%+80.8%1.998% 2/14/2022 Altium Capital Management LP83,931$232K0.1%N/A0.742% (Data available from 1/1/2016 forward) CING Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CING shares? During the previous two years, the following institutional investors and hedge funds held shares of Cingulate shares: Commonwealth Equity Services LLC ($212K), Armistice Capital LLC ($157K), Geode Capital Management LLC ($135K), Jane Street Group LLC ($106K), and Prime Capital Investment Advisors LLC ($48K), AlphaMark Advisors LLC ($25K).Learn more on CING's institutional investors. What percentage of Cingulate stock is owned by institutional investors? 41.31% of Cingulate stock is owned by institutional investors. Learn more on CING's institutional investor holdings. Which institutional investors have been buying Cingulate stock? The following institutional investors have purchased Cingulate stock in the last 24 months: Armistice Capital LLC ($1.24M), Commonwealth Equity Services LLC ($132.52K), Prime Capital Investment Advisors LLC ($48.26K), Geode Capital Management LLC ($27.32K), Jane Street Group LLC ($21.03K), and AlphaMark Advisors LLC ($5K). How much institutional buying is happening at Cingulate? Institutional investors have bought a total of 1,478,925 shares in the last 24 months. This purchase volume represents approximately $13.66M in transactions. Related Companies ALX Oncology Institutional Ownership Lantern Pharma Institutional Ownership PDS Biotechnology Institutional Ownership Immix Biopharma Institutional Ownership Outlook Therapeutics Institutional Ownership VolitionRx Institutional Ownership Shattuck Labs Institutional Ownership Atara Biotherapeutics Institutional Ownership Repare Therapeutics Institutional Ownership Connect Biopharma Institutional Ownership This page (NASDAQ:CING) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendThere's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a tra...Investors Alley | Sponsored2025 AI Blueprint features Nvidia’s march to $5 trillionNvidia is now one of the most valuable companies in the world. It currently ranks second, just behind Apple...Weiss Ratings | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredThe Real Hillbilly ElegyThe mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky...Porter & Company | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 financial crisis over a year in advance. His readers had a chance to lock in g...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cingulate Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cingulate With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
